Show simple item record

dc.contributor.authorOffice of Marketing and Communications. Media Relations
dc.description.abstractThe news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
dc.publisherCornell University, College of Veterinary Medicine
dc.subjectCornell University. College of Veterinary Medicine -- Periodicals.
dc.subjectVanderVen, Brian
dc.subjectRoberts, Lauren Cahoon
dc.subjectCornell Chronicle
dc.title2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs
dc.title.alternativeNew discovery holds potential as tuberculosis drug

Files in this item


This item appears in the following Collection(s)

Show simple item record